NCT06494241Active, not recruiting
Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study
A Multi-Center Study to Evaluate the Guideline Education of Oncology Departments in Small/Middle Tier Cities and County Hospitals for Diagnosis and Treatment Improvement in Patients With Metastatic Non-small Cell Lung Cancer
Source: ClinicalTrials.gov · Last updated 29 Sept 2026
Brief summary (registry, in English)
To evaluate the molecular testing pattern in metastatic NSCLC patients after QIP; To evaluate the treatment pattern in metastatic NSCLC patients after QIP.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 1000 (actual)
- First submitted
- 2 Jul 2024
- Start date
- 22 Nov 2024
- Primary completion date
- 28 Nov 2027
- Lead sponsor
- AstraZeneca
- Diseases
- Lung cancer
- NCT number
- NCT06494241
What you commit to
- Study type: Observational
- Participants enrolled: 1000
- From 22 Nov 2024 to the primary completion date, 28 Nov 2027
- 46 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous enrolment in the other QIP study.
Other
- Be participating in other intervention clinical trials.
- Judgment by the investigator that the participant should not participate in the study if the participant is unlikely to comply with study procedures, restrictions, and requirements.
Who the study is looking for
- Age ≥18 years, at the time of signing the informed consent.
- ECOG performance status 0-2.
- Newly pathologic diagnosed metastatic NSCLC (clinical stage IV) or recurrent metastatic NSCLC.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (46)
Sites in registry order. Pick your city on the disease page to sort them by distance.
This page is information, not medical advice. Discuss any trial with your doctor.